European Agency for the Evaluation of Medicinal Products: fees payable

In adopting the HAUG report, Parliament approved the regulation on fees payable to the European Agency for the Evaluation of Medicinal Products. In its amendments Parliament stated that: - fees should constitute Community resources and any surplus should be assigned to the Community budget; - the Agency's annual estimate should include figures relating to fees for the following financial year; - the codecision procedure (Article 189B) should be applied to the modification of the fees system. �